23rd Annual RIMS Conference: 31 May - 2 June 2018, Amsterdam

Abstract submission is now closed.

Possibilities to present your abstract:
  • There is poster viewing for all abstracts which have been accepted and assigned to either a "Poster Express" session or a "Poster Viewing" session
  • There are express sessions for a selection of accepted abstracts (oral presentation of 1 minute – on stage) – using 1 ppt slide
  • There are platform presentations for a selection of accepted abstracts
    (oral presentation of 10 min incl. 2 min Q&A – on stage) – using PPT slides

Authors that submit an abstract will be asked to indicate their preference to participate in the oral presentations. The reviewers will make a selection of the submitted abstract that qualify for the express sessions or the platform presentation.

Please note: 

General Framework for Abstract Submission
  • The submission of abstracts is welcome and highly appreciated
  • Abstracts should be submitted via the available link on the conference website
  • All submitted abstracts that fullfil the submission criteria, will be screened and considered for presentation by reviewers, appointed by the Scientific Committee, which will send a notification regarding acceptance or rejection of abstracts to the submitting author via email
  • Accepted abstracts are published in the Multiple Sclerosis Journal after the conference
  • There is no cost linked to abstract submission or poster presentation
  • Late breaking abstracts will not be accepted
  • Abstracts with commercial content will not be accepted
  • Posters are centrally displayed close to the plenary room
  • Abstract Submission Deadline by Thursday 15 February, 2018
  • Abstract Submission Feedback regarding acceptance/non-acceptance by Friday 2 March, 2018

Submission Criteria

Abstracts should be uploaded via the abstract submission system accessible via the Conference Website. 
  • All abstracts must be submitted electronically in .pdf format and should be written in English
  • At the time of submission, the material should not have been published or accepted for publication. Encore abstracts are accepted but not favoured
  • The title of the abstract should include all the words crucial for a subject index 
  • The body of the abstract should be limited to maximum 300 words 
  • The subject should treat the results of a specific research project 
  • In addition, there should be a title submitted with a maximum of 45 characters
  • All abstracts have to be submitted by the main author
  • If the abstract has more than one author, the main author should be clearly identified (fe: label: 'main author:') 

Submission Groups 
  • Describing and understanding functioning
  • Outcome Measures
  • Rehabilitation intervention